Abstract
We examined the effectiveness of the Tandem Heart ventricular assist device (Cardiac Assist Inc., Pittsburgh, PA) in patients with severe refractory cardiogenic shock (SRCS). In-hospital mortality of cardiogenic shock remains high, ranging from 45 to 60%. The TandemHeart is a percutaneously
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.